Loss of STARD10 expression identifies a group of poor prognosis breast cancers independent of HER2/Neu and triple negative status.
about
A New Gene Expression Signature for Triple Negative Breast Cancer Using Frozen Fresh Tissue before Neoadjuvant Chemotherapy.Traditional statistical methods for evaluating prediction models are uninformative as to clinical value: towards a decision analytic framework.miR-661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to breast cancer cell invasion by targeting Nectin-1 and StarD10 messengers.Dysregulation of miR-638 in hepatocellular carcinoma and its clinical significance.
P2860
Loss of STARD10 expression identifies a group of poor prognosis breast cancers independent of HER2/Neu and triple negative status.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Loss of STARD10 expression ide ...... eu and triple negative status.
@ast
Loss of STARD10 expression ide ...... eu and triple negative status.
@en
Loss of STARD10 expression ide ...... eu and triple negative status.
@nl
type
label
Loss of STARD10 expression ide ...... eu and triple negative status.
@ast
Loss of STARD10 expression ide ...... eu and triple negative status.
@en
Loss of STARD10 expression ide ...... eu and triple negative status.
@nl
prefLabel
Loss of STARD10 expression ide ...... eu and triple negative status.
@ast
Loss of STARD10 expression ide ...... eu and triple negative status.
@en
Loss of STARD10 expression ide ...... eu and triple negative status.
@nl
P2093
P50
P356
P1476
Loss of STARD10 expression ide ...... Neu and triple negative status
@en
P2093
Adrienne L Morey
C Soon Lee
Catriona M McNeil
Davendra Segara
Elizabeth A Musgrove
Jane E Visvader
Michael Christie
Monilola A Olayioye
Niamh C Murphy
P304
P356
10.1002/IJC.24826
P577
2010-03-01T00:00:00Z